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Copyright © 2009 JCBN Summary Cellular events for neural progenitor cells, such as proliferation and differentiation,
are regulated by multiple intrinsic and extrinsic cell signals. Folate plays a central role in
central nervous system development, so folate, as an extrinsic signal, may affect neural stem
cell (NSC) proliferation and differentiation. In the present study, we investigated the effects of
folate deficiency on the cell proliferation, cell apoptosis and homocysteine concentrations in
NSCs. NSCs were isolated from fetal rats and identified as NSCs by their expression of
immunoreactive nestin. Cell proliferation was quantitated by 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide assay. Apoptotic cells were detected and confirmed by flow
cytometric analysis. We measured homocysteine concentrations in NSCs by high performance
liquid chromatography and detected the expression of caspase-3 by western blot method.
Folate deficiency not only decreased cell proliferation, but also increased the apoptotic rate of
NSCs as demonstrated by the increased expression of early apoptotic markers such as caspase-
3, compared to control group (p<0.05). Furthermore, There was a statistically significant
increase in homocysteine concentration during folate deficiency in NSCs (p<0.05). These data
suggest that folate affects the cell proliferation, apoptosis and homocysteine generation in NSC
cells.
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Introduction
Folate is a nutrient that is best known as a vitamin that
prevents neural tube defects during fetal development.
Recently, it is becoming apparent that folate deficiency also
contributes to many neurological and psychological disorders
including dementia, impaired cognition, depression, psy-
chosis, and Alzheimer’s disease (AD) [1–3]. e.g. diminished
folate levels are associated with a twofold increased risk
in developing AD [4]. The full range of mechanisms by
which deficiencies in folate may contribute to these certain
nervous system diseases is unclear. However, one likely
major impact of folate deprivation is increased in homo-
cysteine (Hcy), since folate is a necessary cofactor for
the enzyme (5,10-methyenetetralhydrofolate reductase) that
mediates conversion of Hcy to methionine. Elevated Hcy
levels are also associated with neuropsychiatric disorders
including AD. Hcy is toxic to cultured neurons and neuronal
cells and potentiates neurotoxicity induced by amyloid-β.
Folate deficiency has been shown to elevate Hcy, compromise
neuronal homesostasis, and render neurons more sensitive to
amyloid toxicity in mouse models of AD and Parkinson’s
disease [5, 6]. To address more fully the neurotoxic effects
of folate deprivation, we examined the consequences of
folate deficiency on neural stem cells (NSCs) in culture.Folate Deficiency and Neural Stem Cell Apoptosis
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Materials and Methods
Reagents
Folate-free Dulbecco’s Modified Eagle’s Medium
(DMEM), N2, B27 supplement, fetal bovine serum (FBS),
basic fibroblast growth factor (bFGF), epidermal growth
factor (EGF), dimethyl sulphoxide (DMSO) were obtained
from Gibco (Carlsbad, CA). During the course of the experi-
ments we have also used the following chemicals: tris-
(2-carboxyl-ethyl)-phosphine, SBD-F (7-fluorobenzo-2-
oxa-1,3-diazole-4-sulphonic acid), folate, d,l-homocysteine,
propidium iodide (PI), cystamine, ethylendiaminetetraacetic
acid (EDTA) and Rnase. All these reagents were purchased
from Sigma (St. Louis, MO). All chemicals and solvents
were of analytical reagent grade. Monoclonal anti-nestin
for immunocytochemistry and polyclonal antibodies against
either caspase-3 or β-actin for western blot analysis were
purchased from Santa Cruz Biotechnology (Santa Cruz,
CA). Fluorescent secondary antibody was obtained from
Zhongshan Goldbridge Biotechnology (Beijing, China).
Primary culture of NSCs
Brain tissue was isolated from fetal rats and washed 3
times with DMEM (control group, liquid media contained
4 mg/L folate). The tissue was cut into small pieces and then
dissociated by incubation with 0.25% parenzyme and 0.02%
EDTA. This step was followed by agitation, centrifugation
and resuspension of the cells in DMEM that was supple-
mented with 2% B27 supplement, 20 ng/mL EGF, 20 ng/mL
bFGF, 2 mmol/L L-glutamine, 100 U/mL penicillin and
phytomycin. The resulting cell suspension was transferred
to a culture flask and grown at 37°C in a humidified
atmosphere containing 95% air 5% CO2. The culture medium
was changed every 2 days.
Identification of cultured cells
Nestin is an intermediate filament protein in NSCs and
other progenitor cells. This protein has been the most exten-
sively used marker to identify NSCs in the developing nervous
system as well as in cultured cells in vitro [7]. Therefore, in
the present study, cultured cells were identified as NSCs by
their expression of immunoreactive nestin. On the sixth day
in culture, immunofluorescence analysis was performed.
The cells were fixed in 4% paraformaldehydein for 30 min
at room temperature and incubated with blocking buffer for
20 min, then permeabilized with 0.1% Triton X-100 in PBS
for 5 min at room temperature. After incubation with 2N
HCl for 30 min at 37°C and then washing with boracic acid
at room temperature, the cells were incubated overnight at
4°C with 1:100 rabbit anti-rat monoclonal anti-nestin anti-
body. Subsequently, cells were incubated for 2 h at room
temperature with TRITC (tetramethylrhodamine isothiocy-
anate)-conjugated goat anti-rabbit IgG.
Assay of cell proliferation
Cultures of NSCs were assigned to one of three treatment
groups: folate deficiency (Folate-D, liquid media contained
0 mg/L folate), normal medium condition group (control
group, liquid media contained 4 mg/L folate), and folate
supplementation group (Folate-S, liquid media contained
40 mg/L folate). Cell proliferation was assessed using the 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay. Briefly, aliquots containing 5 × 105 cells/mL
were transferred to one of 8 wells in a 96-well plate. The
cells were incubated at 37°C within 72, or 96-h period. MTT
(0.5 mg) was added to each well at 4 h before the end of the
incubation period, when the MTT reaction was stopped by
addition of 10% SDS-0.1 mol/L HCl. The cell’s formazan
crystals were dissolved in DMSO, and then absorbance at
490 nm was measured in a Microplate reader (Bio-Tek
ELX800uv, Bio-Tek Instrument Inc, Winooski, VT).
Apoptosis analyses
Apoptotic cells were identified as the percentage by flow
cytometry. After 4 days of cell culture as described above,
cells were harvested and treated with RNase and centrifuged
at 1000 r/min for 10 min at 4°C. The cell pellet was gently
resuspended in 1 mL PI solution at a concentration of 50 μg/
mL in PBS containing 1% Triton-X 100 and 20 μg/mL
RNase and incubated at 4°C in the dark for 30 min. A
minimum of 104 cells/sample was analyzed by using a
FACScan flow cytometry (Becton Dickinson, Mountain
View, CA).
Western blot analysis
Cells were washed with ice-cold PBS and then lysed
with radioimmunoprecipitation assay buffer. Proteins were
separated on SDS-12% polyacrylamide gel and then
transferred to polyvinylidene difluoride membranes. The
membranes were blocked with 5% non-fat milk and incubated
with primary antibody (either rabbit anti-caspase-3 antibody
diluted 1:1,000 or anti-β-actin antibody diluted 1:5,000)
overnight at 4°C and then with a secondary antibody for l h
at room temperature. Proteins were detected by chemilumi-
nescence assay. Quantitation of proteins was done by
densitometric analysis using NIH Image software (version
1.61).
Determination of Hcy levels
Hcy was monitored in proliferated NSCs by HPLC
(high performance liquid chromatography) using a modified
version of the methodology of Araki and Sako (1987) [8].
Cultures were rinsed 2× with TBS (Tris buffer saline),
scraped from the plate in a small volume of TBS, and
homogenized on ice. Aliquots of lysates (50 μL) were
combined with 25 μL of 20 μmol/L cystamine (as an
internal standard) and 25 μL of phosphate buffered salineX.-M. Zhang et al.
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(PBS, pH 7.4). Samples were vortexed, incubated with 10 µL
of 100 g/L tris-(2-carboxyl-ethyl)-phosphine for 30 min at
room temperature. 90 μL of 100 g/L trichloroacetic acid
containing 1 mmol/L EDTA was added for deproteinization.
After the sample was centrifuged for 10 min at 10,000 g,
50 μL of the supernatant was added to an autosampler vial
containing 10 μL of 1.55 mol/L NaOH; 125 μL of 0.125
mol/L borate buffer containing 4 mmol/L EDTA, pH 9.5;
and 50 μL of 1 g/L SBD-F in the borate buffer (0.125 mol/L
pH 9.5). The mixture was then incubated for 60 min at 60°C
and then cooled on ice for subsequent HPLC analysis. A
10 μL aliquot was later injected into the Waters 2795
HPLC system (Waters, Milford, MA). The mobile phase
was 1 mol/L acidacetate buffer, pH 5.0, containing 30 mL/L
methanol at a flow rate 0.7 mL/L.
Statistical analysis
The data were expressed as mean ± SD values and
analyzed by statistical software SPSS13.0 (SPSS Inc.,
Chicago, IL). One-way analysis of variance (ANOVA)
followed by Student-Newman-Keuls (SNK) test for multiple
comparisons were used to determine significant differences
among the experimental groups. The criterion for statistical
significance was p<0.05.
Results
Cell identification
Undifferentiated NSCs formed round neurospheres that
were suspended in the culture medium (Fig. 1A). Almost all
the cells in neurospheres expressed nestin protein, which
was detected as intense red staining of cytoplasm in the
immunofluorescence assay (Fig. 1B).
Effect of folate on NSC proliferation
Significant differences in cell proliferation were detected
between control and Folate-D groups (p<0.05) (Fig. 2).
The effect of folate was concentration dependent, because
proliferation differed significantly between control and
Folate-S (p<0.05) (Fig. 2).
Determination of apoptosis rate with flow cytometry
The quantitative assessment of sub-G1 cells by flow
cytometry was used to estimate the number of apoptotic
cells. Fig. 3 shows that NSC apoptosis was induced in folate
deficiency group that the apoptosis rate was 35.4% ± 1.3%,
whereas 6.5% ± 0.33% of the cells became apoptotic after
treatment with 40 mg/L folate. There was a significant
difference between control and Folate-D groups (p<0.05).
Furthermore, Obvious differences in apoptosis rate between
control and Folate-S groups were also visible (p<0.05).
Folate deprivation activaties caspase-3
Caspases are crucial mediators of apoptosis. Among
Fig. 1. Photomicrographs of cells in neurospheres. (A) Phase contrast photomicrograph of neurospheres (×200). (B) Immuno-
fluorescence staining of cells for nestin (red, ×200).
Fig. 2. Effect of folate on NSC proliferation determined by
MTT assay. Shown are the mean ± SD values from 8 ex-
periments. ap<0.05 vs control group.Folate Deficiency and Neural Stem Cell Apoptosis
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them, caspase-3 is a frequently activated death protease,
catalyzing the specific cleavage of many key cellular
proteins [9]. Therefore upregulation of caspase-3 expression
is an important phenomenon for induction of apoptosis. In
the present investigation, we analyzed the expession level of
caspase-3 by western blot method. A significant increase in
procaspase-3 protein level was detected in folate deprivation
group, compared to control group (p<0.05, Fig. 4).
Furthermore, the results also indicated that folate depriva-
tion resulted in the activation of caspase-3 as evidenced
by the appearance of caspase-active form (20 kDa). This
finding was associated with a significant increase in NSC
apoptosis after folate deprivation treatment by PI staining.
Fig. 3. Measurement of NSC apoptosis rate by flow cytometry. (A) the cells in folate deficiency group with a large apoptosis peak.
Measuring the volume of apoptosis peak. A = 0.35; (B) (C) the cells in control and Folate-S groups with a small apoptosis peak.
Analysis of NSCs treated with 4 mg/L and 40 mg/L folate for 48 h. A = 0.11 and 0.06. a: apoptosis peak.
Fig. 4. Western blot analysis of caspase-3 expression in folate-untreated and treated neural stem cells. After a 48 h folate treatment, cell
proteins were probed with polyclonal antibodies against caspase-3 and β-actin (figure top). Markers indicate caspase-3 precursor
(32 kDa) and the processed form of caspase-3 (20 kDa). A densitometric analysis of immunoblots (figure bottom) was also
carried out after normalization against β-actin. Results were similar in three separate experiments. ap<0.05 vs control.X.-M. Zhang et al.
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Hcy formation following folate deprivation
One likely major impact of folate deprivation is increased
Hcy production [10]. We confirmed that folate deprivation
indeed increased Hcy production by HPLC analyses in
medium of neural stem cell culture. In accordance with
prior studies that demonstrate that increased Hcy formation
increases its export rather than intracellular accumulation
[11]. In folate-D group, Hcy levels within medium of cells
cultured for 3 d increased 2.3-fold compared with folate-S
group (Fig. 5). Cells were treated with folate, which
inhibited Hcy formation.
Discussion
The mammalian central nervous system is organized by a
variety of cells such as neurons and glial cells. These cells
are generated from a common progenitor, NSCs. The fate
of NSC in brain may be regulated by growth factors,
neurotransmitters and nutrients [12]. Folate is an essential
co-factor for the de novo biosynthesis of purines and
thymidylate and hence plays an important role in DNA and
RNA synthesis for the production of new cells [13]. In
addition, clinical trials show that a significant proportion
of NTD recurrences or first occurrence can be prevented by
folic acid supplementation in the periconceptional period.
Reduced levels of folate or vitamin B12 in maternal plasma
are risk factors for NTD. Clinical studies also suggest a
relationship between folate deficiency and neurological and
disorders including Alzheimer’s disease (AD) [1–4]. The
basis for this association has not been clearly defined. It is
likely that the beneficial neurological effects of folate
involve stimulation of NSC proliferation. To investigate
mechanisms underlying this association, we examined the
consequences of folate deprivation and supplementation on
NSC cultures. Our findings demonstrated that folate depri-
vation ultimated apoptosis, whereas folate supplementation
increased NSC proliferation. This finding is consistent with
folate’s well known role as a nutrient essential for the normal
development and functioning of the nervous system.
Dietary folate has a major impact on homocysteine levels,
with an inverse relationship between plasma folate and Hcy
levels. Epidemiological studies have linked folate deficiency
and hyperhomocysteinemia to neurodegenerative and neuro-
psychiatric disease, including Alzheimer and Parkinson
disease, depression, etc. Homocysteine is a neurotoxic non-
proteinogenic amino acid, an abnormal increase of which in
plasma has been implicated in many pathological conditions
including cardiovascular diseases, neural tube defects and is
now recognized and Alzheimer’s disease [14,  15]. Hcy
elimination is regulated by the transmethylation and the
transsulfuration pathways and is modulated by folate.
Metabolic product of folate, 5 methyltetrahydrofolate, pro-
vides a methyl group that is used to reconvert Hcy back to
methionine through the transmethylation pathway. In addi-
tion, the efficiency of folate metabolism has an impact on the
availability of S-adenosylmethionine (SAM), a compound
that is known to activate Hcy flux through the transsulfura-
tion pathway. Some studies in recent years investigated the
role of Hcy as a cause of brain damage. Numerous
neurotoxic effects of Hcy can be blocked by folate. Folate
deficiency can cause decreased SAM. On the other hand,
increased concentration of Hcy is associated with increased
production of SAH via the reverible reaction mediated by
SAH-hydrolase [16, 17]. A lower ratio of SAM/SAH causes
DNA damage and thereby apoptosis, which is one important
explanation for Hcy neurotoxicity.
Some studies showed folate deficiency induces neuro-
toxicity by multiple routes, including increasing cytosolic
calcium and oxidative stress via increasing levels of the
neurotoxin homocysteine, and inducing mitochondrial and
DNA damage [18–20]. One major mechanism by which
folate deprivation is likely to promote neurotoxicity is by
extracellular accumulation of Hcy. As shown herein, folate
deprivation induced Hcy accumulation within medium, these
findings confirm and extend the indication that increased
Hcy mediates a portion of the neurotoxicity resulting from
folate deprivation. Importantly, the activation of caspase-3
has been shown to be essential in the process of Hcy-induced
apoptotic cell death [21,  22]. Here, we observed that
increased Hcy concentrations from folate deprivation
triggerd the activation of caspase 3, the early protein marker
of apoptosis onset in NSCs and may lead to NSC apoptosis.
Conclusions
In summary, the present study showed that the prolifera-
tion of NSCs could be significantly inceased by folate in
concentration-dependent manner, consistent with the results
that folate could inhibit NSC apoptosis. Folate may decrease
Hcy concentration to reduce NSC toxicity.
Fig. 5. Effect of folate on Hcy concentration in NSCs detected
by HPLC. Shown are the mean ± SD values from 8 ex-
periments. ap<0.05 vs control.Folate Deficiency and Neural Stem Cell Apoptosis
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